Licensed Practical Nurse in Du Bois, PA Accepting Medicare

3 Licensed Practical Nurse nurses found. Showing 1 - 3

Deborah L Moate, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Caldwell Dr, Du Bois, PA 15801 Phone: 814-371-1100    Fax: 814-371-3671

Mrs. Toni Sweeney, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 339 Midway Dr, Du Bois, PA 15801 Phone: 814-771-4377

Aimee Renee Cartwright, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Caldwell Dr, Du Bois, PA 15801 Phone: 814-371-1100

News Archive

2,516 potential biomarkers of pancreatic cancer

A cancer scientist from Johns Hopkins has convinced an international group of colleagues to delay their race to find new cancer biomarkers and instead begin a 7,000-hour slog through a compendium of 50,000 scientific articles already published to assemble, decode and analyze the molecules that might herald the furtive presence of pancreatic cancer.

Depomed receives complete response letter for SEFELSA NDA

Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.

Intestinal barrier of IBS patients allows bacteria to pass more freely than in healthy people

The intestinal barrier of patients with the gastrointestinal disease IBS allows bacteria to pass more freely than in healthy people, according to a study led by researchers at Linköping University in Sweden. The study, published in the scientific journal Gastroenterology, is the first to investigate IBS using living bacteria.

Combination therapy disables PI3K/Akt/mTOR pathway and induces apoptosis in carcinoid syndrome

Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.

Read more Medical News

› Verified 1 days ago